Cutler Group’s AtriCure ATRC Stock Holding History

Cutler Group’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,000	Closed	-$94K	–	4359
2020 Q1	$94K	Buy	+15,000	New	+$539K	﹤0.01%	1357
2019 Q2	–	Sell	-4,500	Closed	-$15K	–	4195
2019 Q1	$15K	Buy	+4,500	New	+$137K	﹤0.01%	2206

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Cutler Group's ATRC Position: Q2 2021 in Review

Cutler Group sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 3,500 shares — an estimated $229K sold.

Cutler Group first reported a position in ATRC in Q2 2016 and held it in 5 quarters. The position peaked at $339K in Q1 2020. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

Cutler Group reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
Cutler Group sold 3,500 AtriCure shares in Q2 2021, an estimated $229K.
Cutler Group first reported a position in AtriCure in Q2 2016 and held it in 5 quarters.
Cutler Group's AtriCure position peaked at $339K in Q1 2020.
212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.